Results 161 to 170 of about 4,356,871 (306)

From CRISPR functional genomics to synthetic interventions: engineering antiviral strategies. [PDF]

J Virol
Qiao W.
europepmc   +1 more source

Value [Encyclopedia Entry] [PDF]

, 2005
Davis, John B.
core   +1 more source

Dammarenediol II enhances etoposide‐induced apoptosis by targeting O‐GlcNAc transferase and Akt/GSK3β/mTOR signaling in liver cancer

Molecular Oncology, EarlyView.
Etoposide induces DNA damage, activating p53‐dependent apoptosis via caspase‐3/7, which cleaves PARP1. Dammarenediol II enhances this apoptotic pathway by suppressing O‐GlcNAc transferase activity, further decreasing O‐GlcNAcylation. The reduction in O‐GlcNAc levels boosts p53‐driven apoptosis and influences the Akt/GSK3β/mTOR signaling pathway ...
Jaehoon Lee, Byung‐Cheol Han, Gi‐Bang Koo, Jihye Park, Mijin Kwon, Young Bin Park, Jae‐Mun Choi, Seung‐Ho Lee, Sangho Roh   +8 more
wiley   +1 more source

Prevalence and risk factors for AMS: A systematic review and meta-analysis. [PDF]

PLoS One
Liu X, Tan L, Ren Z, Bai X, Yong S, Gao H, Ba S, Gongga L.   +7 more
europepmc   +1 more source

Family (Encyclopedia entry) [PDF]

, 2008
Coles, Roberta L.
core   +1 more source

Tumor mutational burden as a determinant of metastatic dissemination patterns

Molecular Oncology, EarlyView.
This study performed a comprehensive analysis of genomic data to elucidate whether metastasis in certain organs share genetic characteristics regardless of cancer type. No robust mutational patterns were identified across different metastatic locations and cancer types.
Eduardo Candeal, Andrea Moreno‐Manuel, Miguel Salvadó‐Pertierra, Cristina Santos‐Vivas, Rebeca Sanz‐Pamplona   +4 more
wiley   +1 more source

Residence and insurance inequities in the timeliness of access to first-eye cataract surgery in Eastern China. [PDF]

Int Ophthalmol
Qin C, Zhu J, Yang T.
europepmc   +1 more source

Campbell-Ewald [Encyclopedia Entry] [PDF]

, 2003
Pokrywczynski, James
core   +1 more source

TRAIL‐PEG‐Apt‐PLGA nanosystem as an aptamer‐targeted drug delivery system potential for triple‐negative breast cancer therapy using in vivo mouse model

Molecular Oncology, EarlyView.
Aptamers are used both therapeutically and as targeting agents in cancer treatment. We developed an aptamer‐targeted PLGA–TRAIL nanosystem that exhibited superior therapeutic efficacy in NOD/SCID breast cancer models. This nanosystem represents a novel biotechnological drug candidate for suppressing resistance development in breast cancer.
Gulen Melike Demirbolat, Aslihan Kucuk, Omer Erdogan, Samed Ozer, Bensu Kozan, Tugba Cuceli, Erkan Gumus, Evrim Cevik, Ozge Cevik   +8 more
wiley   +1 more source

Clade C MERS-CoV camel strains vary in protease utilization during viral entry. [PDF]

Proc Natl Acad Sci U S A
Winstone H, Stillwell H, Tan LH, Cohen NA, Perera RAPM, Weiss SR.   +5 more
europepmc   +1 more source